This is the authors' abstract. We don't add key points for this paper.
An 8-year-old girl developed weakness over 2 years and an elevated creatine kinase. The biopsy was most consistent with an active dystrophy with many inflammatory cells present. A trial of immunosuppression was started. In the first 2 months of treatment with prednisone, she had functionally and quantitatively significant improvement in her proximal strength. Over 3 years of treatment she maintained stable strength. Subsequent genetic studies showed that she had primary alpha-sarcoglycan deficiency. The timing and the degree of benefit in strength were similar to that seen in boys with Duchenne muscular dystrophy who are treated with prednisone.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Connolly et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: